Nephrocare Health IPO is to open on December 10, 2025. It is a Mainboard IPO that will raise ₹871.05 crores. The Nephrocare Health IPO price band is fixed at ₹438 to ₹460 with a market lot of 32 Shares.
Nephrocare Health IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | GMP Trend | Gain |
| 5 Dec | ₹- | – | -% |
Nephrocare Health IPO Details
| IPO Open Date | December 10, 2025 |
| IPO Close Date | December 12, 2025 |
| Face Value | ₹2 Per Equity Share |
| IPO Price Band | ₹438 to ₹460 Per Share |
| Issue Size | Approx ₹871.05 Crores |
| Fresh Issue | Approx ₹353.40 Crores |
| Offer for Sale: | Approx 1,12,53,102 Equity Shares |
| Issue Type | Book Built Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Nephrocare Health IPO Dates
| IPO Open Date: | December 10, 2025 |
| IPO Close Date: | December 12, 2025 |
| Basis of Allotment: | December 15, 2025 |
| Refunds: | December 16, 2025 |
| Credit to Demat Account: | December 16, 2025 |
| IPO Listing Date: | December 17, 2025 |
| IPO Bidding Cut-off Time: | December 12, 2025 – 5 PM |
Business Overview
Nephrocare Health Services Ltd. has been in the business of offering end-to-end dialysis care since 2010, with a large network of clinics across India and international markets. Diagnosis, haemodialysis, home and mobile dialysis, and wellness programs are among the services provided by Nephrocare, which also has its own pharmacy.
The company runs a total of 490 clinics, 447 in India and 43 across the Philippines, Uzbekistan, and Nepal as of March 31, 2025. Currently, the business is present in 269 towns in 21 Indian states and four union territories.
As of March 2025, the company had 5068 dialysis machines serving 29,281 patients and performing over 2.88 million dialysis sessions. Max, Fortis Escorts, Care Hospitals, Wockhardt, Paras, CMRI, Jehangir Hospital, and Ruby Hall Clinic are some of the major hospitals the company partnered with to run an in-house dialysis center.
Nephrocare Health IPO GMP aka Grey Market Premium FAQs:
What is Nephrocare Health IPO GMP Today?
What is Nephrocare Health IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Nephrocare Health IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
